Sergey Yurasov

6.9k total citations · 3 hit papers
38 papers, 4.0k citations indexed

About

Sergey Yurasov is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Sergey Yurasov has authored 38 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 15 papers in Immunology. Recurrent topics in Sergey Yurasov's work include Lung Cancer Treatments and Mutations (17 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and T-cell and B-cell Immunology (9 papers). Sergey Yurasov is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and T-cell and B-cell Immunology (9 papers). Sergey Yurasov collaborates with scholars based in United States, Germany and France. Sergey Yurasov's co-authors include Michel C. Nussenzweig, Hedda Wardemann, Eric Meffre, Makoto Tsuiji, Anne Schaefer, James W. Young, Thomas Tiller, Klara Velinzon, Virginia Pascual and Johanna Hammersen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Sergey Yurasov

38 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predominant Autoantibody Production by Early Human B Cell Precursors

2003 1.5k citations Hedda Wardemann, Sergey Yurasov et al. Science profile →
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

2007 672 citations Thomas Tiller, Eric Meffre et al. Journal of Immunological Methods profile →
Defective B cell tolerance checkpoints in systemic lupus erythematosus

2005 515 citations Sergey Yurasov, Hedda Wardemann et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergey Yurasov United States	20	2.8k	1.2k	696	654	490	38	4.0k
Makoto Tsuiji Japan	21	2.2k 0.8×	795 0.7×	749 1.1×	492 0.8×	236 0.5×	39	3.2k
Robert W. Karr United States	32	3.0k 1.1×	912 0.8×	874 1.3×	494 0.8×	343 0.7×	84	4.3k
Joël Plumas France	37	3.7k 1.4×	305 0.3×	1.2k 1.7×	570 0.9×	258 0.5×	104	5.4k
Bernardetta Nardelli United States	23	1.8k 0.6×	455 0.4×	671 1.0×	408 0.6×	166 0.3×	41	2.8k
Chungwen Wei United States	24	2.3k 0.8×	432 0.4×	577 0.8×	773 1.2×	69 0.1×	35	3.2k
P S Linsley United States	21	4.9k 1.8×	620 0.5×	740 1.1×	264 0.4×	135 0.3×	23	6.1k
Elisa Scarselli Italy	28	850 0.3×	687 0.6×	681 1.0×	271 0.4×	218 0.4×	73	3.2k
Jonathan C. Poe United States	37	4.2k 1.5×	1.1k 1.0×	917 1.3×	460 0.7×	52 0.1×	62	5.8k
Joseph M. Ahearn United States	28	2.4k 0.9×	603 0.5×	373 0.5×	1.5k 2.2×	79 0.2×	62	3.5k
Gary S. Gray United States	27	3.2k 1.2×	582 0.5×	1.2k 1.7×	106 0.2×	263 0.5×	36	5.4k

Countries citing papers authored by Sergey Yurasov

Since Specialization

Citations

This map shows the geographic impact of Sergey Yurasov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Yurasov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Yurasov more than expected).

Fields of papers citing papers by Sergey Yurasov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Yurasov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Yurasov. The network helps show where Sergey Yurasov may publish in the future.

Co-authorship network of co-authors of Sergey Yurasov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Yurasov. A scholar is included among the top collaborators of Sergey Yurasov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Yurasov. Sergey Yurasov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Jyoti D., James Stevenson, Hui Chen, et al.. (2024). EP.12H.01 A Phase 2 Study to Assess BDTX-1535, An Oral EGFR Inhibitor, in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S657–S657. 2 indexed citations

Pollack, Seth M., Neeta Somaiah, Dejka M. Araujo, et al.. (2020). Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States. Cancer Medicine. 9(13). 4593–4602. 15 indexed citations

Wakelee, Heather A., Jonathan W. Goldman, Shirish M. Gadgeel, et al.. (2016). PS01.66: Biomarker Stratification of Outcomes of Third-Generation EGFR TKI Therapy in Patients with Previously-Treated Advanced NSCLC. Journal of Thoracic Oncology. 11(11). S311–S312. 1 indexed citations

Gadgeel, S., J.C. Soria, Heather A. Wakelee, et al.. (2015). 3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test. European Journal of Cancer. 51. S628–S628. 1 indexed citations

Camidge, D. Ross, Eamon M. Berge, Robert C. Doebele, et al.. (2014). A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(10). 1532–1539. 41 indexed citations

Garon, Edward B., Dachuang Cao, Ekaterine Alexandris, et al.. (2012). A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design. Clinical Lung Cancer. 13(6). 505–509. 33 indexed citations

Doebele, Robert C., David R. Spigel, Mustapha Tehfé, et al.. (2012). A Phase 2 Randomized Open-Label Study of Ramucirumab (IMC 1121b; RAM) in Combination with Platinum-Based Chemotherapy in Patients (PTS) with Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC): Results From Non-Squamous (NSQ) PTS (NCT01160744). Annals of Oncology. 23. ix408–ix408. 9 indexed citations

Scheid, Johannes F., Hugo Mouquet, J. Köfer, et al.. (2011). Differential regulation of self-reactivity discriminates between IgG ⁺ human circulating memory B cells and bone marrow plasma cells. Proceedings of the National Academy of Sciences. 108(44). 18044–18048. 56 indexed citations

Herzog, Cynthia E., Tanya Trippett, Joseph F. Grippo, et al.. (2010). Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors. Clinical Cancer Research. 17(3). 611–619. 41 indexed citations

10.

Tiller, Thomas, Makoto Tsuiji, Sergey Yurasov, et al.. (2007). Autoreactivity in Human IgG+ Memory B Cells. Immunity. 26(2). 205–213. 356 indexed citations

11.

Yurasov, Sergey & Michel C. Nussenzweig. (2007). Regulation of autoreactive antibodies. Current Opinion in Rheumatology. 19(5). 421–426. 46 indexed citations

12.

Tiller, Thomas, Eric Meffre, Sergey Yurasov, et al.. (2007). Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. Journal of Immunological Methods. 329(1-2). 112–124. 672 indexed citations breakdown →

13.

Yurasov, Sergey, Thomas Tiller, Makoto Tsuiji, et al.. (2006). Persistent expression of autoantibodies in SLE patients in remission. The Journal of Experimental Medicine. 203(10). 2255–2261. 104 indexed citations

14.

Tsuiji, Makoto, Sergey Yurasov, Klara Velinzon, et al.. (2006). A checkpoint for autoreactivity in human IgM+ memory B cell development. The Journal of Experimental Medicine. 203(2). 393–400. 153 indexed citations

15.

Yurasov, Sergey, Johanna Hammersen, Thomas Tiller, Makoto Tsuiji, & Hedda Wardemann. (2005). B‐Cell Tolerance Checkpoints in Healthy Humans and Patients with Systemic Lupus Erythematosus. Annals of the New York Academy of Sciences. 1062(1). 165–174. 29 indexed citations

16.

Wardemann, Hedda, Sergey Yurasov, Anne Schaefer, et al.. (2003). Predominant Autoantibody Production by Early Human B Cell Precursors. Science. 301(5638). 1374–1377. 1518 indexed citations breakdown →

17.

Pettoello‐Mantovani, Massimo, Christina Raker, Sergey Yurasov, et al.. (2000). Mice Transgenic for Monocyte-Tropic HIV Type 1 Produce Infectious Virus and Display Plasma Viremia: A New in Vivo System for Studying the Postintegration Phase of HIV Replication. AIDS Research and Human Retroviruses. 16(5). 481–492. 20 indexed citations

18.

Yurasov, Sergey, Massimo Pettoello‐Mantovani, Christina Raker, & Harris Goldstein. (1999). HIV Type 1 Infection of Human Fetal Bone Marrow Cells Induces Apoptotic Changes in Hematopoietic Precursor Cells and Suppresses Their in Vitro Differentiation and Capacity to Engraft SCID Mice. AIDS Research and Human Retroviruses. 15(18). 1639–1652. 8 indexed citations

19.

Pettoello‐Mantovani, Massimo, Tobias R. Kollmann, Christina Raker, et al.. (1998). thy/liv‐SCID‐hu Mice: A System for Investigating the In Vivo Effects of Multidrug Therapy on Plasma Viremia and Human Immunodeficiency Virus Replication in Lymphoid Tissues. The Journal of Infectious Diseases. 177(2). 337–346. 20 indexed citations

20.

Yurasov, Sergey, Tobias R. Kollmann, Christina Raker, et al.. (1997). Severe Combined Immunodeficiency Mice Engrafted With Human T Cells, B Cells, and Myeloid Cells After Transplantation With Human Fetal Bone Marrow or Liver Cells and Implanted With Human Fetal Thymus: A Model for Studying Human Gene Therapy. Blood. 89(5). 1800–1810. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact